How Bariatric Surgery Affects Cancer Risk — Mechanistic R21 (no clinical trials)
The NCI invites R21 applications to study biological mechanisms by which bariatric surgery (especially RYGB and sleeve gastrectomy) changes cancer risk using animal models and/or human biospecimens; clinical trials are not allowed. Projects must link molecular, microbial, or metabolic mechanisms to actual cancer endpoints rather than epidemiology or biomarker-only outcomes, and multidisciplina…
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites applications for support of investigator-initiated studies addressing mechanisms by which bariatric surgery impacts cancer risk, and seeks to draw in talented scientists who study bariatric surgery to …
Funding Source
Awards & funding
Eligibility
- Foreign/Non-domestic entities: Non-domestic (non-U.S.) Entities (Foreign Organizations) are NOT eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are NOT eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed in applicati…
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers